Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-01-13
1999-05-04
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514300, 514312, 514926, 514927, A61K 31435
Patent
active
059004134
ABSTRACT:
An infection with Helicobacter may successfully be treated with a compound of the formula ##STR1## wherein R.sub.1 is hydrogen or methyl and R.sub.2 is hydrogen or L-alanine-L-alanyl, and the pharmaceutically acceptable acid additive salts thereof. These compounds are useful in the treatment of gastric and duodenal ulcers.
REFERENCES:
patent: 5164402 (1992-11-01), Brighty
Trimoulet et al, Enfermedades Digestivas, 78(1), Nov. 1990.
J. R. Warren and B. Marshall, The Lancet, 1273-5 (1983).
Fedotin, Modern Medicine, 60, 61-70 (1992).
Czinn et al, Adv. Pediatr. Infect. Dis. (90), 5, 221-37 1994.
NIH Consensus Devt. Conf., 77-79, Feb. 7-9, 1994.
Canton et al., Rev. Esp. Enf. Digest, 78 (Suppl. I), 98(102), abstract #P-209 (1990).
Peyre et al., Rev. Esp. Enf. Digest, 78 (Suppl. I), 107, abstract #P-232 (1990).
Daskalopoulos et al., Rev. Esp. Enf. Digest, 78 (Suppl. I), 113, abstract #P-244 (1990).
Molnar et. al., Irish J. Med. Science, 161 (Suppl. 10), 99, abstract #T44 (1992).
Bayerdorffer et al., Deutsche Medizinische Wochenschrift, 112, 1407-1411 (1987).
Hardy et al., J. Antimicrob. Chemother, 22, 631-636 (1988).
Sachdeva et al., ICAAC, 107, abstract # 41 (1989).
Labenz et al., Rev. Esp. Enf. Digest, 78 (Suppl. I) 104, abstract #P-224 (1990).
Glupczynski et al. The Lancet: May 9, 1987, 1096 (1987).
Stone et al., J. Antmicrob. Chemother, 22, 92-93 (1988).
Mertens et al., Antimicrob. Agents Chemother, 33, 256-257 (1989).
Forsmark et al., J. Infect. Dis., 162, 998 (1990).
Vicenzi et al., Rev. Esp. Enf. Digest, 78 (Suppl. I), 114, abstract #P-248 (1990).
Westblom et al., J. Infect. Dis., 165, 974-975 (1992).
Haas et al., Antimicrob. Agents Chemother, 34, 1637-1641 (1990).
Caekenberghe et al., Antimicrobial Agents and Chemotherapy, 31, 1429-1430 (1987).
Nakao et al., Eur. J. Clin. Microbiol. Infect. Dis., 14, 391-399 (1995).
Colin-Jones, Lancet, 1467 (1987).
NIH Consensus Development Conference on Helicobacter pylori in Peptic Ulcer Disease, Feb. 7-9 (1994).
Carley et al., J. Antimicrobial Chemotherapy, 24, 266-268 (1989).
Glupczynski et al., Eur. J. Epidemiol., 4, 154-157 (1988).
McNulty et al., Eur. J. Clin. Microbiol Infect. Dis., 7, 566-569 (1988).
Marshall, Gastroenterology Clinics of North America, 22, 183-198 (1993).
Simor et al., Antimicrobial Agents and Chemotherapy, 33, 108-109 (1989).
Girard Arthur E.
Gootz Thomas D.
Cook Rebecca
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
Zielinski Bryan C.
LandOfFree
Treatment of H. pylori infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of H. pylori infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of H. pylori infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1869637